Key Takeaways Alcon's Unity VCS received Health Canada approval, with commercial launch expected in early 2026. Unity VCS offers faster nucleus removal, less energy use, and the world's fastest vitrectomy probe. ALC shares rose 0.3% on the news and have gained 2.5% YTD, outpacing a 9.2% industry decline.Alcon Inc.’s (ALC) UNITY Vitreoretinal Cataract System (“VCS”) has recently received approval from Health Canada. UNITY VCS is the latest innovation from the Alcon Vision Suite — a portfolio of innovative ...